Effect of exercise combined with glucagon-like peptide-1 receptor agonist treatment on cardiac function: A randomized double-blind placebo-controlled clinical trial

Peter G. Jørgensen; Magnus T. Jensen; Pernille Mensberg; Heidi Storgaard; Signe Nyby; Jan S. Jensen; Filip K. Knop; Tina Vilsbøll

doi:10.1111/dom.12900

Effect of exercise combined with glucagon-like peptide-1 receptor agonist treatment on cardiac function: A randomized double-blind placebo-controlled clinical trial

Diabetes Obesity and Metabolism ◽

10.1111/dom.12900 ◽

2017 ◽

Vol 19 (7) ◽

pp. 1040-1044 ◽

Cited By ~ 15

Author(s):

Peter G. Jørgensen ◽

Magnus T. Jensen ◽

Pernille Mensberg ◽

Heidi Storgaard ◽

Signe Nyby ◽

...

Keyword(s):

Clinical Trial ◽

Cardiac Function ◽

Receptor Agonist ◽

Controlled Clinical Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1

Download Full-text

Efficacy and tolerability of tirzepatide, a dual glucose‐dependent insulinotropic peptide and glucagon‐like peptide‐1 receptor agonist in patients with type 2 diabetes: A 12‐week, randomized, double‐blind, placebo‐controlled study to evaluate different dose‐escalation regimens

Diabetes Obesity and Metabolism ◽

10.1111/dom.13979 ◽

2020 ◽

Vol 22 (6) ◽

pp. 938-946 ◽

Cited By ~ 5

Author(s):

Juan Pablo Frias ◽

Michael A. Nauck ◽

Joanna Van ◽

Charles Benson ◽

Ross Bray ◽

...

Keyword(s):

Type 2 Diabetes ◽

Dose Escalation ◽

Receptor Agonist ◽

Controlled Study ◽

Double Blind ◽

Double Blind Placebo ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1 ◽

Insulinotropic Peptide

Download Full-text

Efficacy and safety of once-weekly glucagon-like peptide 1 receptor agonist albiglutide (HARMONY 1 trial): 52-week primary endpoint results from a randomized, double-blind, placebo-controlled trial in patients with type 2 diabetes mellitus not controlled

Diabetes Obesity and Metabolism ◽

10.1111/dom.12382 ◽

2014 ◽

Vol 16 (12) ◽

pp. 1257-1264 ◽

Cited By ~ 62

Author(s):

J. Reusch ◽

M. W. Stewart ◽

C. M. Perkins ◽

D. T. Cirkel ◽

J. Ye ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Receptor Agonist ◽

Controlled Trial ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1

Download Full-text

Metabolic improvement with short‐term glucagon like peptide‐1 receptor agonist treatment does not improve cardiac diastolic dysfunction in patients type 2 diabetes: a randomized double‐blind placebo‐controlled trial

Diabetes Obesity and Metabolism ◽

10.1111/dom.14480 ◽

2021 ◽

Author(s):

Annemie Stege Bojer ◽

Martin Heyn Sørensen ◽

Jenny Bjerre ◽

Peter Gæde ◽

Niels Vejlstrup ◽

...

Keyword(s):

Type 2 Diabetes ◽

Diastolic Dysfunction ◽

Receptor Agonist ◽

Controlled Trial ◽

Short Term ◽

Double Blind ◽

Double Blind Placebo ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1

Download Full-text

Weekly glucagon-like peptide-1 receptor agonist albiglutide as monotherapy improves glycemic parameters in Japanese patients with type 2 diabetes mellitus: A randomized, double-blind, placebo-controlled study

Journal of Diabetes Investigation ◽

10.1111/jdi.12749 ◽

2017 ◽

Vol 9 (3) ◽

pp. 558-566 ◽

Cited By ~ 1

Author(s):

Antonio Nino ◽

Inaha Okuda ◽

Timothy H Wilson ◽

Lynn Yue ◽

Hiromu Nakajima ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Receptor Agonist ◽

Japanese Patients ◽

Controlled Study ◽

Double Blind ◽

Double Blind Placebo ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1

Download Full-text

Efficacy and safety of the glucagon-like peptide-1 receptor agonist liraglutide added to insulin therapy in poorly regulated patients with type 1 diabetes--a protocol for a randomised, double-blind, placebo-controlled study: The Lira-1 study

BMJ Open ◽

10.1136/bmjopen-2015-007791 ◽

2015 ◽

Vol 5 (4) ◽

pp. e007791-e007791 ◽

Cited By ~ 9

Author(s):

T. F. Dejgaard ◽

F. K. Knop ◽

L. Tarnow ◽

C. S. Frandsen ◽

T. S. Hansen ◽

...

Keyword(s):

Type 1 Diabetes ◽

Insulin Therapy ◽

Receptor Agonist ◽

Controlled Study ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1

Download Full-text

Effects of the glucagon-like peptide-1 receptor agonist liraglutide on systolic function in patients with coronary artery disease and type 2 diabetes: a randomized double-blind placebo-controlled crossover study

Cardiovascular Diabetology ◽

10.1186/s12933-016-0425-2 ◽

2016 ◽

Vol 15 (1) ◽

Cited By ~ 31

Author(s):

Preman Kumarathurai ◽

Christian Anholm ◽

Olav W. Nielsen ◽

Ole P. Kristiansen ◽

Jens Mølvig ◽

...

Keyword(s):

Type 2 Diabetes ◽

Coronary Artery Disease ◽

Receptor Agonist ◽

Systolic Function ◽

Double Blind ◽

Double Blind Placebo ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1 ◽

Artery Disease

Download Full-text

Test 1: Treatment of dysferlinopathy with deflazacort: a double-blind, placebo-controlled clinical trial

Gene ◽

10.1016/s0378-1119(15)30104-4 ◽

2015 ◽

Author(s):

Jerry Lewis ◽

Lauren Bacall ◽

Humphrey Bogart ◽

Gene Kelly

Keyword(s):

Clinical Trial ◽

Controlled Clinical Trial ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Double blind placebo controlled clinical trial of homoeopathic medicines in HIV infection

British Homeopathic Journal ◽

10.1038/sj.bhj.5800206 ◽

1998 ◽

Vol 87 (2) ◽

pp. 86-88

Author(s):

D P Rastogi ◽

V P Singh ◽

Vikram Singh ◽

S K Dey ◽

K Rao

Keyword(s):

Clinical Trial ◽

Hiv Infection ◽

Controlled Clinical Trial ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

A Magnetic Resonance Spectroscopy Study of Lovastatin for Treating Bipolar Mood Disorder: A 4-Week Randomized Double-Blind, Placebo- Controlled Clinical Trial

Recent Patents on Inflammation & Allergy Drug Discovery ◽

10.2174/1872213x10666161028153258 ◽

2017 ◽

Vol 10 (2) ◽

pp. 133-141 ◽

Cited By ~ 2

Author(s):

Mehrzad Lotfi ◽

Sara Shafiee ◽

Ahmd Ghanizadeh ◽

Motahar O. Sigaroudi ◽

Leila Razeghian

Keyword(s):

Clinical Trial ◽

Magnetic Resonance ◽

Magnetic Resonance Spectroscopy ◽

Controlled Clinical Trial ◽

Resonance Spectroscopy ◽

Spectroscopy Study ◽

Double Blind ◽

Double Blind Placebo ◽

Magnetic Resonance Spectroscopy Study ◽

Bipolar Mood Disorder

Download Full-text

Beneficial effect of Burdock complex on asymptomatic Helicobacter pylori- infected subjects: A randomized, double-blind placebo-controlled clinical trial

Helicobacter ◽

10.1111/hel.12469 ◽

2018 ◽

Vol 23 (3) ◽

pp. e12469 ◽

Cited By ~ 3

Author(s):

Chi-Hua Yen ◽

Hui-Fang Chiu ◽

Su-Yu Huang ◽

Yan-Ying Lu ◽

Yi-Chun Han ◽

...

Keyword(s):

Clinical Trial ◽

Helicobacter Pylori ◽

Beneficial Effect ◽

Controlled Clinical Trial ◽

Double Blind ◽

Double Blind Placebo

Download Full-text